Related Experiment Videos

[Resistance phenotypes circulating in nosocomial high risk departments]

Monica Licker1, Roxana Moldovan, Luminiţa Bădiţoiu

  • 1Catedra de Microbiologie, UMF Victor Babeş Timişoara.

Bacteriologia, Virusologia, Parazitologia, Epidemiologia (Bucharest, Romania : 1990)
|April 17, 2004
PubMed
Abstract

Insights

This study identified multiple drug-resistant bacteria in Intensive Care Units (ICUs), highlighting their role in patient colonization and nosocomial infections. Findings emphasize the need for expert interpretation of antibiotic resistance patterns and consistent hospital antimicrobial policies.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Nosocomial infections pose a significant threat in Intensive Care Units (ICUs).
  • Understanding bacterial colonization and infection patterns is crucial for effective patient management.
  • Identifying circulating bacterial phenotypes in ICUs aids in infection control strategies.

Purpose of the Study:

  • To assess bacterial colonization and infection in hospitalized adult and newborn ICU patients.
  • To identify bacteria with nosocomial potential.
  • To determine the prevalent bacterial phenotypes within ICUs.

Main Methods:

  • Collected 406 patient samples from November 2001 to January 2002.
  • Utilized API (bioMerieux) for bacterial identification.
  • Performed antimicrobial susceptibility testing using API and Kirby-Bauer disc-diffusion methods.

Main Results:

  • Isolated 295 bacterial strains with nosocomial potential.
  • Identified 34 Methicillin-resistant Staphylococcus aureus (MRSA) strains.
  • Detected 23 Methicillin-resistant Coagulase-Negative Staphylococcus (MRCNS) strains and 29 ESBL-producing gram-negative rods.

Conclusions:

  • Observed widespread presence of multidrug-resistant bacteria in ICUs.
  • Confirmed the significant role of these bacteria in patient colonization and nosocomial infections.
  • Recommended bacteriologist interpretation of antibiotic resistance and consistent hospital antimicrobial policies.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...